At the news
? BULLISHIMPACT 6/10 8-K filed Aug 4, 2026 at 16:08 ET
DaVita reported Q2 2026 diluted EPS of $4.02 on consolidated revenues of $3.554B. The EPS beat the Street consensus of $4.01 by a marginal 0.25%, while revenue exceeded the $3.49B estimate by 1.8%. The company maintained its full-year 2026 guidance for adjusted operating income ($2.15B-$2.25B) and adjusted diluted EPS ($14.10-$15.20), signaling confidence in operational momentum despite a slight sequential decline in revenue per treatment.
- Q2 2026 diluted EPS of $4.02 vs consensus $4.01 (beat by 0.25%)
- Q2 2026 consolidated revenues of $3.554B vs consensus $3.49B (beat by 1.8%)
- Revenue grew 5.2% YoY from $3.380B in Q2 2025
- Operating income of $579M (16.3% margin) vs $538M (15.9%) in Q2 2025
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access